Related Experiment Video
Updated: Aug 4, 2026
13:51
The MultiBac Protein Complex Production Platform at the EMBL
Published on: July 11, 2013
Summary
India's biotechnology sector faces legal challenges impacting its growth. Current investment levels are examined to determine if they can sustain the industry amidst regulatory changes.
Area of Science:
- Biotechnology Law and Regulation
- Indian Economic Policy
- Investment and Finance
Background:
- India's biotechnology industry has experienced significant growth.
- Recent legislative changes pose potential risks to the sector's expansion.
- The industry relies heavily on sustained investment for innovation and development.
Purpose of the Study:
- To analyze the impact of recent legal changes on India's biotechnology industry.
- To assess the adequacy of current investment levels in ensuring the sector's future viability.
- To identify potential challenges and opportunities for the biotechnology sector.
Main Methods:
- Review of relevant legislation and policy documents.
- Analysis of investment trends and financial data in the biotechnology sector.
- Expert interviews and case studies.
Main Results:
- The new legal framework introduces uncertainties that could deter investment.
- While investment is substantial, its allocation and long-term commitment are crucial.
- Specific sub-sectors may be disproportionately affected by the regulatory shifts.
Conclusions:
- The future of India's biotechnology industry is contingent on navigating regulatory hurdles.
- Sustained and strategic investment is necessary but may not be sufficient without policy clarity.
- Proactive adaptation and policy dialogue are essential for continued industry success.
Related Concept Videos
01:09Recombinant DNA
Overview
02:55Synthetic Biology
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Golden rice
Golden rice is a genetically modified...
01:20The Central Dogma
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...